Truist Financial Corp Horizon Therapeutics Public LTD CO Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $87,597 - $102,429	-885 Reduced 31.95%	1,885 $218,000
Q2 2023 Aug 01, 2023	SELL	$96.34 - $112.38 $430,543 - $502,226	-4,469 Reduced 61.74%	2,770 $284,000
Q1 2023 May 05, 2023	SELL	$107.32 - $113.5 $6.58 Million - $6.96 Million	-61,321 Reduced 89.44%	7,239 $790,000
Q4 2022 Feb 17, 2023	SELL	$62.39 - $113.8 $1.11 Million - $2.03 Million	-17,805 Reduced 20.62%	68,560 $7.8 Million
Q3 2022 Oct 26, 2022	BUY	$58.92 - $84.67 $212,583 - $305,489	3,608 Added 4.36%	86,365 $5.35 Million
Q2 2022 Jul 22, 2022	SELL	$79.4 - $116.36 $931,520 - $1.37 Million	-11,732 Reduced 12.42%	82,757 $6.6 Million
Q1 2022 Apr 22, 2022	BUY	$86.42 - $109.81 $452,927 - $575,514	5,241 Added 5.87%	94,489 $9.94 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $205,596 - $250,132	2,086 Added 2.39%	89,248 $9.62 Million
Q3 2021 Nov 05, 2021	BUY	$91.91 - $110.37 $242,182 - $290,824	2,635 Added 3.12%	87,162 $9.55 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $399,808 - $444,685	4,636 Added 5.8%	84,527 $7.92 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $2.18 Million - $2.9 Million	30,328 Added 61.19%	79,891 $7.35 Million
Q4 2020 Nov 19, 2021	SELL	$67.0 - $84.39 $544,710 - $686,090	-8,130 Reduced 14.09%	49,563 $3.63 Million
Q4 2020 Feb 18, 2021	BUY	$67.0 - $84.39 $3.13 Million - $3.95 Million	46,768 Added 428.08%	57,693 $4.22 Million
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $184,633 - $267,205	-3,343 Reduced 23.43%	10,925 $848,000
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $119,108 - $224,729	3,944 Added 38.2%	14,268 $792,000
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $4,849 - $7,519	195 Added 1.93%	10,324 $305,000
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $257,580 - $371,430	10,129 New	10,129 $366,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account